Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
-
FDA Approves the Zenflow Spring® Implant and Delivery System for First-Line Interventional Therapy of Patients with Benign Prostatic Hyperplasia (BPH)
-
ITHAX Acquisition Corp. III Announces Pricing of $200 Million Initial Public Offering
-
Air Canada’s 2025 12 Days of Holiday Cheer: A Year of Expanding Global Connections and Elevating the Passenger Experience
-
BlueGrace Logistics Joins Triumph Network
-
Top Technology Executives Recognized at the 2025 St. Louis ORBIE Awards
-
Financial Institutions, Inc. Announces Completion of $80.0 Million Private Placement of Subordinated Notes
-
Results from the Annual Shareholders Meeting
-
Host Hotels & Resorts Announces Fourth Quarter Dividend and Special Dividend on Common Stock
-
National Healthcare Properties Announces Closing of New $550 Million Senior Unsecured Credit Facility
-
ATN Board Declares Quarterly Dividend
-
Monument Announces Declaration of Special Dividend
-
Destination XL Group, Inc. Reports Third Quarter Financial Results
-
Quanex Building Products Announces Fourth Quarter and Full Year 2025 Results
-
Costco Wholesale Corporation Reports First Quarter Fiscal Year 2026 Operating Results
-
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
-
Navitas Expands Global Distribution Network with Avnet
-
Destination XL Group and FullBeauty Brands to Combine in Merger of Equals, Creating a Scaled, Category-Defining Retailer for Inclusive Apparel
-
CORRECTION -- Lifeway Issues Letter to Shareholders Regarding Dissident Director Nominees, Revealing Disqualifying Track Records and Ethical Failures
-
OFA Group Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Capital Structure and Advancing Digital Asset Strategy
-
Lamar Advertising Company Announces Cash Dividends on Common Stock
-
Costco Wholesale Corporation Reports First Quarter Fiscal Year 2026 Operating Results
-
Kitron secures EUR 17 million contract for combat vehicle components
-
Arteris to Expand Portfolio with Acquisition of Cycuity, a Leader in Semiconductor Cybersecurity Assurance
-
Adamas Trust Declares Fourth Quarter 2025 Common Stock Dividend of $0.23 Per Share, and Preferred Stock Dividends
-
Northann Corp. Receives Non-Compliance Notice from NYSE American
-
Arbor Realty SR, Inc. Prices Offering of $400 Million of 8.50% Senior Notes due 2028
-
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Datavault AI Inc. (NASDAQ: DVLT) Announces a Distribution Date of Dec. 24, 2025, for the Dream Bowl Meme Coin Tokens to All Eligible Record Equity Holders of Datavault AI and Holders of Common Stock o
-
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
-
Netskope Announces Strong Third Quarter Fiscal Year 2026 Financial Results
-
BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Epsilon Energy Ltd. Announces the Divestment of Dewey Energy Holdings LLC and the Company’s Asset in the Anadarko Basin
-
FAST TRACK GROUP and CloudX Entertainment Announce Strategic Partnership to Expand Celebrity and Influencer Amplification for Brands
-
LPL Welcomes Forest Lake Wealth Partners to Linsco
-
Lesaka Webcast and Conference Call to Review Second Quarter 2026 Results
-
Frequency Electronics, Inc. Announces Second Quarter and Fiscal Year 2026 Financial Results
-
Ramon Sanchez Joins Firefly Aerospace as Chief Operating Officer
-
Tenaya Therapeutics Announces Proposed Public Offering
-
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results
-
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
-
Preferred Bank Announces Dividend Increase
-
Nusano Receives “Best Companies to Work For” Award from Utah Business
-
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
-
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
-
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
-
Oruka Therapeutics Announces New Board Member and Board Transition
-
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
